InvestorsObserver is giving Athira Pharma Inc (ATHA) an Analyst Rating Rank of 25, meaning ATHA is ranked higher by analysts than 25% of stocks. The average price target for ATHA is $18.5 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating ATHA a Buy today. Find out what this means to you and get the rest of the rankings on ATHA!